Patients with NYHA functional class III or IV are less likely to tolerate medical therapy due to reasons such as hyperkalemia, hypotension, or renal dysfunction, which develops with higher doses of beta blockers or ACE inhibitors. Here, ACE is linked to Hyperkalemia.